ESC 365 - hs-troponin should be used in unselected patients with suspected ACS. PRO.

ACVC Premium Access

hs-troponin should be used in unselected patients with suspected ACS. PRO.

Session: Controversies in diagnostic strategies for chest pain patients

Topic: Biomarkers

Speaker: Professor B. Lindahl (Uppsala, SE)

Event: Acute Cardiovascular Care 2019

Congress Presentation

Add to my library

About the speaker

Professor Bertil Lindahl

Uppsala University, Uppsala (Sweden)

14 presentations

4 followers

5 more presentations in this session

hs-troponin should be used in unselected patients with suspected ACS. CONTRA.

Speaker: Professor M. Moeckel (Berlin, DE)

hs-troponin should be used in unselected patients with suspected ACS. Discussion.

We need to add a risk score to hs-troponin - PRO.

Speaker: Doctor M. Tubaro (Rome, IT)

We need to add a risk score to hs-troponin - CONTRA.

Speaker: Associate Professor J. Boeddinghaus (Edinburgh, GB)

We need to add a risk score to hs-troponin - Discussion.

Access the full session

Controversies in diagnostic strategies for chest pain patients

Speakers: Professor B. Lindahl, Professor M. Moeckel, Doctor M. Tubaro, Associate Professor J. Boeddinghaus

About the event

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources